Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology
Roy D. Altman(Unknown), Clarence L. Young
Cited by 486
Related Papers
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
|Proceedings of the National Academy of Sciences|2018|556
Exercise and education versus saline injections for knee osteoarthritis: a randomised controlled equivalence trial
|Annals of the Rheumatic Diseases|2021|295